We are live on ! Find out more
AC

Arjuna Capital Portfolio holdings

AUM $393M
1-Year Est. Return 20.42%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+20.42%
3 Year Est. Return
+74.87%
5 Year Est. Return
+103.01%
10 Year Est. Return
AUM
$372M
AUM Growth
+$19M
Cap. Flow
+$3.69M
Cap. Flow %
0.99%
Top 10 Hldgs %
43.05%
Holding
113
New
13
Increased
66
Reduced
18
Closed
12

Top Buys

Rank Stock Value
1
AMP icon
Ameriprise Financial
AMP
+$4.3M
2
HPQ icon
HP
HPQ
+$3.18M
3
SON icon
Sonoco
SON
+$3.05M
4
WM icon
Waste Management
WM
+$2.9M
5
NVDA icon
NVIDIA
NVDA
+$2.44M

Top Sells

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$4.27M
2
CMCSA icon
Comcast
CMCSA
+$3.78M
3
EXPD icon
Expeditors International
EXPD
+$3.58M
4
CSCO icon
Cisco
CSCO
+$3.37M
5
UNH icon
UnitedHealth
UNH
+$3.33M

Sector Composition

Rank Sector Weight
1 Technology 32.01%
2 Healthcare 13.01%
3 Financials 12.55%
4 Consumer Discretionary 10.79%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
26
Ameriprise Financial
AMP
$48.1B
$4.3M 1.16%
+10,056
New +$4.3M
LOW icon
27
Lowe's Companies
LOW
$118B
$4.17M 1.12%
18,933
+291
+2% +$66.4K
AVGO icon
28
Broadcom
AVGO
$1.85T
$4.03M 1.08%
25,110
+250
+1% +$35K
APOG icon
29
Apogee Enterprises
APOG
$832M
$3.95M 1.06%
62,912
+22,577
+56% +$1.4M
NUE icon
30
Nucor
NUE
$58.5B
$3.81M 1.03%
24,132
-7,615
-24% -$1.32M
CL icon
31
Colgate-Palmolive
CL
$73.3B
$3.69M 0.99%
38,004
+314
+0.8% +$29K
CVS icon
32
CVS Health
CVS
$134B
$3.57M 0.96%
60,414
+1,143
+2% +$71.5K
HPQ icon
33
HP
HPQ
$24.6B
$3.51M 0.94%
+100,165
New +$3.18M
BCO icon
34
Brink's
BCO
$4.84B
$3.35M 0.9%
32,711
+15,739
+93% +$1.5M
MA icon
35
Mastercard
MA
$510B
$3.34M 0.9%
7,578
-3,771
-33% -$1.72M
LRCX icon
36
Lam Research
LRCX
$373B
$3.24M 0.87%
30,420
-18,760
-38% -$1.8M
BEPC icon
37
Brookfield Renewable
BEPC
$6.04B
$3.17M 0.85%
111,573
-2,678
-2% -$74.9K
V icon
38
Visa
V
$684B
$3.11M 0.84%
11,851
+96
+0.8% +$26.3K
AMT icon
39
American Tower
AMT
$81.3B
$2.84M 0.76%
14,598
+150
+1% +$28K
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$122B
$2.82M 0.76%
6,007
+50
+0.8% +$21.7K
SON icon
41
Sonoco
SON
$5.62B
$2.68M 0.72%
+52,886
New +$3.05M
A icon
42
Agilent Technologies
A
$39.2B
$2.6M 0.7%
20,044
+9,868
+97% +$1.38M
HMN icon
43
Horace Mann Educators
HMN
$2.1B
$2.56M 0.69%
78,465
+1,206
+2% +$42.2K
CMCSA icon
44
Comcast
CMCSA
$84B
$2.55M 0.69%
65,058
-96,601
-60% -$3.78M
EXPD icon
45
Expeditors International
EXPD
$21.8B
$2.51M 0.68%
20,113
-30,025
-60% -$3.58M
ADBE icon
46
Adobe
ADBE
$98.5B
$2.43M 0.66%
4,383
+49
+1% +$23.7K
BDX icon
47
Becton Dickinson
BDX
$45.6B
$2.31M 0.62%
9,874
+117
+1% +$27.6K
WLY icon
48
John Wiley & Sons Class A
WLY
$2.66B
$2.21M 0.6%
54,378
+37,019
+213% +$1.41M
NFLX icon
49
Netflix
NFLX
$305B
$2.14M 0.58%
31,750
-710
-2% -$44.3K
KMB icon
50
Kimberly-Clark
KMB
$36.6B
$2.01M 0.54%
+14,558
New +$1.94M

Similar funds

Arjuna Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Arjuna Capital held 113 positions worth $372M, up 5.4% from $353M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Arjuna Capital's Q2 2024 filing shows 13 new, 66 increased, 18 reduced and 12 closed positions. Its largest new stake was Ameriprise Financial: 10,056 shares worth $4.3M. The largest sale was Bank of New York Mellon, an estimated $4.27M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Arjuna Capital's largest Q2 2024 buy was Ameriprise Financial: 10,056 shares worth $4.3M.
  • Arjuna Capital added most to Waste Management in Q2 2024, an estimated $2.9M increase.
  • Arjuna Capital's biggest Q2 2024 reduction was Comcast, cutting an estimated $3.78M.
  • Arjuna Capital fully exited Bank of New York Mellon in Q2 2024, selling an estimated $4.27M.
  • Arjuna Capital's ten largest holdings make up 43% of its $372M portfolio in Q2 2024.
  • Arjuna Capital opened 13 new positions and closed 12 in Q2 2024.
  • Arjuna Capital's portfolio value rose 5.4% quarter-over-quarter to $372M.

Based on Arjuna Capital's 13F filing for Q2 2024, filed 29 Jul 2024.